Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
JAMA Network Open
|
February 27, 2020
Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial
Fiona M Walter, Merel M Pannebakker, Matthew E Barclay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel
Nicholas Coupe, Pippa Corrie, Mirela Hategan, et al.
British Journal of Cancer
|
February 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma
Alimu Dayimu, Lorena Di Lisio, Shubha Anand, et al.
Medicine
|
February 13, 2015
Salvage pancreaticoduodenectomy after complete response to chemoradiotherapy for a previously unresectable pancreatic adenosquamous carcinoma: a case report
Anne Elias, Nikolaos A Chatzizacharias, Athanasios Xanthis, et al.
Cancer Immunology, Immunotherapy : CII
|
December 3, 2013
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
Nicola E Annels, Victoria E Shaw, Rachel F Gabitass, et al.
British Journal of Cancer
|
March 24, 2023
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study
Lewis A Hall, Siobhan C McKay, James Halle-Smith, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2023
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Drew W Rasco, Theresa Medina, Pippa Corrie, et al.
British Journal of Cancer
|
July 10, 2020
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position
Christopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2023
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Ishan Mehta, Alimu Dayimu, Satish Kumar, et al.
Pigment Cell & Melanoma Research
|
January 19, 2017
Genomic analysis and clinical management of adolescent cutaneous melanoma
Roy Rabbie, Mamunur Rashid, Ana M Arance, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
JAMA Network Open
|
February 27, 2020
Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial
Fiona M Walter, Merel M Pannebakker, Matthew E Barclay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel
Nicholas Coupe, Pippa Corrie, Mirela Hategan, et al.
British Journal of Cancer
|
February 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma
Alimu Dayimu, Lorena Di Lisio, Shubha Anand, et al.
Medicine
|
February 13, 2015
Salvage pancreaticoduodenectomy after complete response to chemoradiotherapy for a previously unresectable pancreatic adenosquamous carcinoma: a case report
Anne Elias, Nikolaos A Chatzizacharias, Athanasios Xanthis, et al.
Cancer Immunology, Immunotherapy : CII
|
December 3, 2013
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
Nicola E Annels, Victoria E Shaw, Rachel F Gabitass, et al.
British Journal of Cancer
|
March 24, 2023
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study
Lewis A Hall, Siobhan C McKay, James Halle-Smith, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2023
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Drew W Rasco, Theresa Medina, Pippa Corrie, et al.
British Journal of Cancer
|
July 10, 2020
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position
Christopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2023
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Ishan Mehta, Alimu Dayimu, Satish Kumar, et al.
Pigment Cell & Melanoma Research
|
January 19, 2017
Genomic analysis and clinical management of adolescent cutaneous melanoma
Roy Rabbie, Mamunur Rashid, Ana M Arance, et al.
Page
of 6